Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M115,068Revenue $M139,367Net Margin (%)3.3Z-Score3.6
Enterprise Value $M50,653EPS $4.0Operating Margin %6.3F-Score6
P/E(ttm))25.6Cash Flow Per Share $4.1Pre-tax Margin (%)5.5Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %12.4Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.95-y EBITDA Growth Rate %11.2Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow11.4y-y EBITDA Growth Rate %7.9ROA % (ttm)6.4Higher Current Ratio y-yN
Dividend Yield %1.2Insider Buy (3m)0ROE % (ttm)12.2Less Shares Outstanding y-yY
Payout Ratio %28.0Shares Outstanding M1,125ROI % (ttm)8.1Gross Margin Increase y-yN

Gurus Latest Trades with CVS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSNWQ Managers 2014-12-31 Reduce-0.57%$78.81 - $98.25
($88.16)
$ 102.2614%Reduce -33.62%1,287,296
CVSChris Davis 2014-12-31 Sold Out -0.53%$78.81 - $98.25
($88.16)
$ 102.2614%Sold Out0
CVSRobert Olstein 2014-12-31 Reduce-0.18%$78.81 - $98.25
($88.16)
$ 102.2614%Reduce -18.48%75,000
CVSScott Black 2014-12-31 Reduce-0.18%$78.81 - $98.25
($88.16)
$ 102.2614%Reduce -13.03%108,124
CVSVanguard Health Care Fund 2014-12-31 Reduce-0.08%$78.81 - $98.25
($88.25)
$ 102.2614%Reduce -8.50%4,015,136
CVSRay Dalio 2014-12-31 Buy 0.04%$78.81 - $98.25
($88.16)
$ 102.2614%New holding55,411
CVSTom Gayner 2014-12-31 Add0.04%$78.81 - $98.25
($88.25)
$ 102.2614%Add 6.42%232,000
CVSMario Gabelli 2014-12-31 Reduce-0.02%$78.81 - $98.25
($88.25)
$ 102.2614%Reduce -2.54%1,489,263
CVSJames Barrow 2014-12-31 Reduce$78.81 - $98.25
($88.25)
$ 102.2614%Reduce -1.71%352,989
CVSJoel Greenblatt 2014-12-31 Reduce$78.81 - $98.25
($88.32)
$ 102.2614%Reduce -44.87%5,154
CVSKen Fisher 2014-12-31 Add$78.81 - $98.25
($88.25)
$ 102.2614%Add 0.91%142,036
CVSRuane Cunniff 2014-12-31 Reduce$78.81 - $98.25
($88.25)
$ 102.2614%Reduce -6.03%24,953
CVSPRIMECAP Management 2014-12-31 Reduce$78.81 - $98.25
($88.25)
$ 102.2614%Reduce -0.36%3,186,930
CVSJohn Rogers 2014-12-31 Reduce$78.81 - $98.25
($88.25)
$ 102.2614%Reduce -1.68%93,675
CVSChris Davis 2014-09-30 Reduce-1.52%$76.11 - $82.24
($78.94)
$ 102.2623%Reduce -76.10%2,153,905
CVSNWQ Managers 2014-09-30 Reduce-0.14%$76.11 - $82.24
($78.94)
$ 102.2623%Reduce -8.48%1,939,169
CVSJoel Greenblatt 2014-09-30 Reduce-0.05%$76.11 - $82.24
($78.94)
$ 102.2623%Reduce -85.79%9,348
CVSTom Gayner 2014-09-30 Add0.05%$76.04 - $82.24
($78.83)
$ 102.2623%Add 10.66%218,000
CVSScott Black 2014-09-30 Reduce-0.02%$76.04 - $82.24
($78.83)
$ 102.2623%Reduce -1.76%124,326
CVSMario Gabelli 2014-09-30 Reduce-0.01%$76.04 - $82.24
($78.83)
$ 102.2623%Reduce -2.28%1,528,010
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Brennan Troyen AEVP, Chief Medical Officer 2015-03-23Sell33,274$104.94-2.81view
BROWN C DAVID IIDirector 2015-03-20Sell25,000$104.3-2.21view
Roberts Jonathan CEVP & President, CVS/caremark 2015-01-07Sell86,487$95.317.01view
MERLO LARRY JPresident and CEO 2015-01-05Sell144,144$94.38.15view
Lofberg Per GHEVP 2015-01-02Sell347,343$95.287.04view
Brennan Troyen AEVP, Chief Medical Officer 2015-01-02Sell50,240$95.716.56view
Sussman AndrewSVP & Pres, CVS/minuteclinic 2015-01-02Sell4,220$95.676.61view
Foulkes HelenaEVP, President-CVS/pharmacy 2014-11-07Sell46,325$88.0615.82view
Bisaccia LisaSVP, Chief HR Officer 2014-10-27Sell33,507$8519.99view
Sussman AndrewSVP & President, MinuteClinic 2014-09-02Sell9,020$79.4528.37view

Press Releases about CVS :

    Quarterly/Annual Reports about CVS:

    News about CVS:

    Articles On GuruFocus.com
    Mario Gabelli Comments on CVS Health Corp Mar 12 2015 
    Selected Comments of Mario Gabelli from Barron's 2015 Roundtable & The Gabelli Asset Fund Q4 2014 Co Mar 12 2015 
    Gabelli Growth Fund Q4 Commentary Feb 24 2015 
    Looking Ahead of Wall Street: Coca-Cola, PepsiCo, CVS Health Feb 09 2015 
    Gilead Sciences Offering Fresh Wave Of Competition To AbbVie’s Viekira Pak Feb 06 2015 
    Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition? Jan 22 2015 
    18 Cool Dividend Growth Large Caps For A Hot Market Jan 14 2015 
    Weekly Insider Sells Highlight: CVS, MNST, CAG, EVHC Jan 11 2015 
    Weekly CEO Sells Highlight: Six Flags Entertainment Corp, Gilead Sciences Inc, Ingersoll-Rand PLC, C Jan 11 2015 
    Oakmark Equity and Income Fund Fourth Quarter 2014 Commentary Jan 09 2015 

    More From Other Websites
    Final Glance: Drugstore companies Mar 26 2015
    Final Glance: Drugstore companies Mar 26 2015
    Final Glance: Drug Benefits companies Mar 26 2015
    Final Glance: Drug Benefits companies Mar 26 2015
    Blue Ridge Capital Opens New Position in Walgreens Boots Alliance Mar 26 2015
    Midday Glance: Drugstore companies Mar 26 2015
    Midday Glance: Drugstore companies Mar 26 2015
    Midday Glance: Drug Benefits companies Mar 26 2015
    Midday Glance: Drug Benefits companies Mar 26 2015
    Pay Up For Quality Because You'll Rarely Be Disappointed -- 4 Stocks To Buy Now Mar 26 2015
    Early Glance: Drugstore companies Mar 26 2015
    Early Glance: Drugstore companies Mar 26 2015
    Early Glance: Drug Benefits companies Mar 26 2015
    Early Glance: Drug Benefits companies Mar 26 2015
    Taking Aim at Three Health Care Charts -- Celgene, CVS, ISIS Mar 23 2015
    After Target wage hike, labor groups turn to drugstore chains Mar 23 2015
    After Target wage hike, labor groups turn to drugstore chains Mar 20 2015
    New Cholesterol Meds May Lower Heart Risks, but Will They Break the Bank? Mar 20 2015
    New Type of Cholesterol Drug Could Prove Costly Mar 19 2015
    Price Concerns Follow News About Cholesterol Drug Mar 19 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK